NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells
about
Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytesThe oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2The viral etiology of AIDS-associated malignanciesEpstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis.Epstein-Barr virus latent genesTo be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosisHost-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.Cellular disorganization and extensive apoptosis in the developing heart of mice that lack cardiac muscle alpha-actin: apparent cause of perinatal deathLupeol is one of active components in the extract of Chrysanthemum indicum Linne that inhibits LMP1-induced NF-κB activationGenetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activationc-Rel deficiency increases caspase-4 expression and leads to ER stress and necrosis in EBV-transformed cellsIdentification and Function of MicroRNAs Encoded by HerpesvirusesInhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cellsEpstein-Barr virus: 40 years onEBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.Yeast genetic selections to optimize RNA decoys for transcription factor NF-kappa BEpstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infectionAssociation between NFKB1 -94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis.RNA Viruses: ROS-Mediated Cell Death.Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma.Dual expression of Epstein-Barr virus, latent membrane protein-1 and human papillomavirus-16 E6 transform primary mouse embryonic fibroblasts through NF-κB signalingAn Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3AEpstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growthLatent membrane protein 1 is dispensable for Epstein-Barr virus replication in human embryonic kidney 293 cells.Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation.Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosisThe NF-κB genomic landscape in lymphoblastoid B cells.Molecular virology of Epstein-Barr virus.Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.SplicerEX: a tool for the automated detection and classification of mRNA changes from conventional and splice-sensitive microarray expression data.The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell linesToll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1Virus and cell RNAs expressed during Epstein-Barr virus replicationEBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth.Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines.RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines.IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.CD20 antibody primes B lymphocytes for type I interferon production.
P2860
Q24646670-664F4A98-2D60-4F71-B560-1D24B2F427ECQ24674848-B2001D2A-3A6D-4610-916B-65D0C5937A12Q24685892-889B833F-6D51-4117-B12E-958554441E34Q24816875-B1349455-63AC-429B-83B1-AD23BB9C052DQ28082701-71855A19-40AE-438F-AB2C-1661ABFA682AQ28190313-E1F02159-7E87-429F-A13D-FFE75C3230EBQ28386446-59AE08D3-405F-4207-83A7-B3E199D5E460Q28513099-A63A06C2-8CD3-49C4-88F9-3C8F1DFCCA27Q28535439-53157E6F-DEA3-40CA-BF3A-4C2B7B799C3DQ28731826-C412665B-87AD-41F6-ABB7-834B1947D00DQ28744344-1C54F482-3991-4D2F-AFF8-20AC516D2286Q28749288-2D49B14B-CAC0-4721-8619-9A18BD1F8DD4Q29303134-FBF3DAAF-8F36-4D9D-BD78-C5D73DB61086Q29617969-51C2CDE8-DDE9-42CF-B5AD-332268720760Q30837949-B11E1BFF-0803-4463-A434-C0EE2B8F8B3BQ30897995-35A88F30-CFD1-4228-8E60-A772A397FF89Q33658144-0886324D-2029-435B-813D-36DAFF93E11EQ33661771-5E332014-40A6-4FE1-A916-79B01C0406C9Q33668416-10AC6285-8388-4A03-9B68-25BDDFBB4D8EQ33714992-4E7B0E7C-9DF8-441F-BF87-7F487DA1E132Q33802649-7CE62CB2-DEB6-417E-B5DC-BD961A646064Q33854424-293469CD-2463-4784-9F89-49B6A0DA2AD7Q33953070-628C6E81-5FBA-425B-9BBF-C5675DFA3F8FQ33996858-30660BC6-2079-4658-9114-DB377BE20B50Q34059398-5AD3477E-B6C1-4507-851F-98AADB7C78A1Q34131747-46E6194E-4DBD-49D9-98CA-E35FAEA5D5DEQ34154616-66B7C195-0598-4372-BA99-8FEC84B784E9Q34175522-0C2AC910-37E2-4D3B-945B-7DFD62503FBBQ34225554-1C5559A3-5571-49EA-B3EA-3BEA6A02F752Q34241279-0893F002-8D5C-4E54-A9D2-5FDDF312CF36Q34318040-3740A4AC-7552-48FA-8195-907C9BC5C31AQ34327176-779AFBEC-1CA5-4679-98CA-864E1E92450CQ34405076-A6D8C1F0-619F-41B2-B16B-C1756FC8B077Q34434702-980B16AC-A68B-482E-A3AA-DDBD2C80CC60Q34465612-F833A954-867A-4542-9A4C-724F3FFD3F66Q34472101-F7D36777-5D63-452E-B9DA-337916F4F512Q34478739-1F14915F-0D46-45C0-A15A-4FCDF862F3E4Q34479733-600B0AD9-7EA3-4A9D-BD6F-296C95BE5724Q34789652-2AF836B1-29B4-42AC-B1A5-9A488B5BF3E5Q34846171-2B32264B-F894-4938-9C70-55A29D2DBB28
P2860
NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
NF-kappa B inhibition causes s ...... ansformed lymphoblastoid cells
@ast
NF-kappa B inhibition causes s ...... ansformed lymphoblastoid cells
@en
NF-kappa B inhibition causes s ...... ansformed lymphoblastoid cells
@nl
type
label
NF-kappa B inhibition causes s ...... ansformed lymphoblastoid cells
@ast
NF-kappa B inhibition causes s ...... ansformed lymphoblastoid cells
@en
NF-kappa B inhibition causes s ...... ansformed lymphoblastoid cells
@nl
prefLabel
NF-kappa B inhibition causes s ...... ansformed lymphoblastoid cells
@ast
NF-kappa B inhibition causes s ...... ansformed lymphoblastoid cells
@en
NF-kappa B inhibition causes s ...... ansformed lymphoblastoid cells
@nl
P2093
P2860
P921
P356
P1476
NF-kappa B inhibition causes s ...... ansformed lymphoblastoid cells
@en
P2093
D M Davidson
E D Cahir-McFarland
S L Schauer
P2860
P304
P356
10.1073/PNAS.100119497
P407
P577
2000-05-23T00:00:00Z